JENNY BALTAZAR: Open Payments
NPI 1851579619 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 33 payments from 11 companies in 2025. Trend: 2023 $645 · 2024 $1,218 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $281 |
| GlaxoSmithKline, LLC. | 5 | $124 |
| Actelion Pharmaceuticals US, Inc. | 1 | $102 |
| Pulmonx Corporation | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Vifor Pharma, Inc. | 2 | $50 |
| Insmed, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Viatris Specialty LLC | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: AIRSUPRA, UPTRAVI, TEZSPIRE, TRELEGY ELLIPTA, CHARTIS CATHETER, GLASSIA, Zemaira, Arikayce.
Industry payments across FL — which companies pay providers there.
